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Abstract The hyperimmunoglobulinemia D and periodic 
fever (hyper-IgD) syndrome is typified by recurrent 
febrile attacks with abdominal distress, joint involvement 
(arthralgias/arthritis), headache, skin lesions, and an ele­
vated serum IgD level (>100U/ml). This familial disorder 
has been diagnosed in 56 subjects worldwide. As the hy­
per-IgD syndrome resembles familial Mediterranean 
fever, one could speculate that both result from mutations 
in the same gene. The gene causing familial Mediter­
ranean fever (MEF) has been located on chromosome 
16p. We have studied 10 families with 19 affected and 28 
non-affected subjects. The clinical findings and IgD deter­
minations from these families are compatible with autoso­
mal recessive inheritance. Using highly polymorphic 
markers surrounding the MEF gene, only negative Lod 
scores were obtained, whereas haplotype analysis ex­
cluded this locus as the cause of the hyper-IgD syndrome. 
In addition, no indication for linkage was obtained with 
markers from other candidate gene regions on chromo­
somes 17q and 14q.
Introduction
The hyperimmunoglobulinemia D and periodic fever syn­
drome (hyper-IgD) is a rare entity characterized by recur­
rent attacks of fever (Van der Meer et al. 1984). Symp­
toms start at an early age and persist throughout life 
(Drenth et al. 1994a). Diagnosis is made by using clinical 
criteria allowing distinction from other periodic fever syn-
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dromes, such as familial Mediterranean fever (FMF), 
adult-onset Still’s disease, and juvenile chronic arthritis 
(Drenth et al. 1994a). Typically, the attacks occur every 
4-8 weeks and last 3-7 days; they are accompanied by ab­
dominal distress (vomiting, diarrhoea, and pain), joint in­
volvement (arthralgia/arthritis), skin lesions, headache, 
and lymphadenopathy (Drenth et al. 1994a, b; Van der 
Meer et al. 1984). All patients have a persistently elevated 
polyclonal serum IgD level (> 100U/ml) (Hiemstra et al. 
1989). The pathogenesis of the hyper-IgD syndrome re­
mains an enigma and consequently therapy is solely sup­
portive. So far, 56 patients (29 male/27 female) from nine 
countries have been diagnosed. Autosomal recessive in­
heritance is suggested by the finding that in seven fami­
lies, two or more sibs are affected, whereas the parents are 
unaffected. Serum IgD measurements in one family re­
vealed high values in patients and low values in unaf­
fected members (<100 U/ml), supporting the concept of 
autosomal recessive inheritance (Reeves and Mitchell 
1984).
The febrile attacks of the hyper-IgD syndrome and 
FMF have much in common, despite some clinical differ­
ences, such as lymphadenopathy (rare in FMF), serositis 
(rare in hyper-IgD syndrome), and amyloidosis (not seen 
in hyper-IgD syndrome). Both syndromes are typified by 
recurrent abdominal distress, articular symptoms, and 
skin manifestations.
There are also similarities in the biochemical changes 
that accompany attacks, namely, high erythrocyte sedi­
mentation rate, leukocytosis, and high levels of C-reactive 
protein (Drenth et al. 1994a; Meyerhoff 1980). In view of 
these similarities, it could be speculated that FMF and the 
hyper-IgD syndrome are variants of one condition (Feder- 
spiel and Tonz 1987; Majeed and Barakat 1989), and that 
both syndromes are allelic and produced by defects in the 
same gene. Initially, in Israeli families of North African 
and Iraqi (non-Askhenazi) descent, linkage was indicated 
between FMF and markers on chromosome 17q22-q24 
(Aksentijevich et al. 1993a). A maximum multipoint Lod 
score of 3.27 was reached approximately 10 centimorgans 
(cM) telomeric to D17S40. Subsequent linkage studies
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have how ever  failed to support ch rom osom e 17q as the 
location for the responsible gene (Aksentijevich et al. 
1993a). In the same non-Askhenazi  Israeli families, the 
gene causing F M F  (the M E F  gene) could be m apped  to 
the short arm o f  ch rom osom e 16 (Pras et al. 1992). Using 
marker  D 16S84  ( 16p 13.3), a lod score o f  9.17 was 
reached at a recombination frequency (9) o f  0.04. These  
results also pertain to Armenian  families suffering from 
F M F  (Shohat et al. 1992). Refined mapping with highly 
polymorphic  markers resulted in the localization o f  the 
M E F  gene less than 1 cM  centromeric  from D 16S246  
(Aksentijevich et al. 1993b; Levy et al. 1993). Such accu­
rate localization allows us to exam ine  the role of  the M E F  
gene in the hyper-IgD syndrome.
Materials and methods
Patients
The present study included 10 families with members suffering 
from the hyper-IgD syndrome (Fig. 1). Seven families originate 
from the Netherlands (nos. 2, 5, 8-10), the other three families are 
from the United Kingdom (no. 6), France (no. 1), and Spain (no. 
7), respectively. There were no consanguineous marriages. In total, 
19 affected and 28 non-affected family members were investi­
gated. The clinical data pertaining to these patients have been pub­
lished elsewhere and the diagnosis of hyper-IgD syndrome was 
made according to published criteria (Drenth et al. 1994a). Briefly, 
the patients suffer from life-long recurrent self-limiting attacks of 
fever, with no known antigenic triggers, lasting 3 -7  days and ac­
companied by one or a combination of the following symptoms: 
abdominal distress (vomiting, diarrhea, pain), skin manifestations, 
arthralgia/arthritis, and/or lymphadenopathy. A detailed family 
history and pedigree were obtained by interviewing each patient; a 
comprehensive medical history was also taken from each unaf­
fected family member. Immunoglobulin D concentrations were 
measured by enzyme-linked immunosorbent assay with a detection 
limit of 1 U/ml. The study was approved by the Medical Ethics 
Committee of the University Hospital St Radboud, Nijmegen.
DNA analysis
Blood was sampled from relevant family members, and genomic 
DNA was isolated according to the method of Miller et al. (1988). 
The markers studied were D16S418, D16S423, D16S283, and 
D16S291 (chromosome 16p 13.3), D17S515 (chromosome 17q22- 
24), and D14S78 (chromosome 14q32-33).
All markers were analyzed using polymerase chain reaction 
amplification of genomic DNA (50 ng) in a 15-ml reaction mixture 
containing 200 |JM  of each dATP, dGTP, dTTP, 2.5 jjM  dCTP, 0.6 
jiCi 32P-dCTP (10mCi/ml, 3000Ci/mmol), 1 x Supertaq buffer 
[ lOm M  TRIS-HC1 p H 9.0, 5 0 mM  KC1, 1.5 mM  MgCl2, 0.1% Tri­
ton X - 100, 0.01 % (w/v) gelatin] and 0.06 U Supertaq (HT Biotech­
nology, United Kingdom) overlayed with mineral oil. After an ini-
Fig. 1 Ten hyper-IgD families 
studied for linkage analysis 
with polymorphic markers. In 
total, 19 affected patients and 
33 non-affected family m em ­
bers were present. Results of 
IgD measurements in U/ml are 
shown for each individual. 
Note the high serum IgD con­
centrations in patients (>100 
U/ml) and the low values for 
unaffected individuals (<100 
U/ml)
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Table 1 Linkage analysis be­
tween the gene for hyper-IgD 
syndrome and markers of can­
didate regions for the eene
Marker Location Lodscores 0
0.00 0.01 0.05 0.1 0.2 0.3 0.4
D16S291 16q 13.3 —  C O -5 .64 -2 .36 -1 .16 -0.31 -0 .07 -0.01
D16S283 16q 13.3 —  O D -5 .08 -2 .43 -1 .40 -0 .54 -0 .18 -0 .04
D 16S423 16q 13.3 —  O O -6 .58 -2 .72 -1 .35 -0 .38 -0 .09 -0.01
D16S418 16q 13.3 —  O O -7 .09 -3 .17 -1 .70 -0 .56 -0 .16 -0.03
D17S515 17q22 —  O O -10 .6 -5 .19 -3 .02 -1 .18 -0.41 -0.08
D14S78 14q32.3 —  O O -4.21 -1 .62 -0 .68 -0 .04 -0 .07 0.03
tial dénaturation for 5 min at 94°C, amplification was performed 
with 30 cycles of 94°C for 1 min, 55°C for 2 min, and 72°C for 1 
min, followed by a final extension of 6 min at 72°C (Weber and 
May 1989). The reactions were performed in a 96-well thermal cy­
cler (M.J. Research, Watertown, Mass, USA). After amplification, 
samples were analyzed on a 6.6% polyacrylamide gel (acrylamide: 
N,N’-methylene bisacrylamide 19:1) containing 8.3 M urea, 1 x T B E  
(100 mA'/ TRIS-borate. 2 mM  EDTA pH 8.3). Electrophoresis was 
performed at 60 W for 2 -4  h. After drying of the gels, bands were 
visualized by overnight exposure to Kodak X-OMAT S film.
Statistical analysis
Linkage analysis was performed using the MLINK subroutine of 
the computer program LINKAGE (version 5.10) (Lathrop et al. 
1985). Lod score calculations were performed on the basis of au­
tosomal recessive inheritance with a gene frequency for the hyper- 
IgD syndrome of 0.00001 and complete penetrance.
Results and discussion
Ten families with the hyper-IgD syndrome were studied 
(Fig. 1) in order to test the hypothesis  that the hyper-IgD 
syndrom e and F M F  are caused by the same gene. The 
clinical findings from these families supported the au toso­
mal recessive mode of  inheritance o f  the hyper-IgD syn­
drome. This was further substantiated by the analysis o f  
IgD levels in patients and in non-affected family m e m ­
bers. All patients had elevated serum IgD levels varying 
from 266 U/ml to 4 2 2 4 U/ml, whereas all non-affected 
persons had levels below the cut-off point o f  100 U/ml 
and ranging from 0 .4 -6 0  U/ml (Fig. 1). Highly po lym or­
phic markers surrounding the M E F  gene were selected for 
linkage analysis. As can be seen in Table 1, only negative 
Lod scores were obtained and a region o f  at least lOcM  
surrounding each m arker  locus was excluded as the loca­
tion o f  the responsible gene (Z < -2 ) .  Because three o f  the 
marker  loci have been m apped within 5 c M  from the M E F  
gene (Fig. 2), our results exclude the M E F  gene as the 
cause for the hyper-IgD syndrome. This  finding was fur­
ther corroborated by the construction o f  haplotypes in two 
o f  the largest families (nos. 2 and 3; F ig .3A , B) (T hom p­
son 1987). Focusing on the chrom osom es  o f  the mother in 
family 2, it appears that each copy o f  the relevant segment 
has been inherited by her affected children. Furthermore, 
individuals II.4 and II.5 have similar haplotypes, although 
only male II.4 is clinically affected (F ig .3A).  In family 3, 
a comparison o f  the haplotypes o f  sibs II.2 and II.4, who 
are both affected, reveals that they have inherited different
combinations of  parental segments  o f  16p (F ig .3B).  
These findings exclude the M E F  gene as the cause for hy­
per-IgD syndrome in these families. After the exclusion of  
the M E F  gene, we decided to test two other candidate re­
gions.
Markers from the region 17q22-q24 have previously 
shown linkage with the disorder in a subset o f  M E F  fam ­
ilies (Aksentijevich et al. 1993a). Multi-point linkage 
analysis indicates that the most likely position o f  the gene 
was at lOcM  telomeric to D17S40. However,  linkage 
analysis in our families with the marker  D17S515, which 
has been mapped at this location (N IH /C E PH  collabora­
tive mapping group 1992), resulted in a negative lod score 
(Table 1). A region o f  about 30 cM surrounding this m ark­
er locus was excluded; this argues against the 17q region 
as the location o f  the gene for hyper-IgD syndrome.
Another  candidate locus is the im m unoglobulin  heavy 
chain gene cluster on ch rom osom e 14q32.3 (Hofker  et al. 
1989). The high serum IgD concentration persists during
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Fig. 2 Order of polymorphic markers surrounding the MEF gene. 
The genetic distances (sex averaged) are given in cM according to 
the Genome Data Base (Aksentijevich et al. 1993b). The hatched 
box indicates the location of the MEF gene. The asterisks point to 
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Fig. 3 Haplotype analysis of A
the relevant area of chromo­
some 16p for family 2 (A) and 
family 3 (B). The orientation 
of the markers is 16pter- 
D 16 S 2 9 1 - D 16S283-D 16S423- 
D16S418-16cen. Haplotypes 
were assigned in such a way as 
to minimize the number of 
crossovers in each family 
(Thompson 1987)
A C
A C
B B
B C
I
\\\
A C
A C
B B
A C Ì
B
D D N\\
— A B \\
\
\
— C B \\
\
\
A D \
D C
A B
C A
A B
C G
B A
A A
B D
////////
\\
\\\\\\\\\N\
D G
B A
B A
D F
/
/ ./////////VL
C G
B A
A A
B F
////
/////Z
C D
A B
C B
A D
S
*\\
$
2 4
non-symptomatic periods, and other serum immunoglobu­
lins such as IgA and IgG3 can also be elevated in patients 
with hyper-IgD syndrome. One could therefore speculate 
that a mutation at the Ig-locus might interfere with the 
regulation of several members of the gene cluster. Al­
though such a mutation would be anticipated to act domi­
nantly, we have performed linkage analysis with the 
marker D14S78, which is located an estimated distance of 
8 cM from the Ig-locus. Although the Ig-locus cannot be 
firmly excluded (Table 1), the negative Lod score would 
not support the presence of a mutation in the im­
munoglobulin heavy chain gene cluster causing hyper- 
IgD syndrome.
In summary, linkage analysis in 10 families with the 
hyper-IgD syndrome demonstrates that, despite many of 
the symptoms of the hyper-IgD syndrome being similar to 
FMF, the MEF gene can be unequivocally excluded as the 
primary disease locus for the hyper-IgD syndrome. This 
finding firmly establishes that the hyper-IgD syndrome 
and FMF are two distinct genetic disorders. Furthermore, 
we have found no indication of linkage with markers on 
chromosome 17q (foregoing evidence suggested linkage 
with FMF) or 14q (immunoglobulin heavy chain cluster). 
The localization of the gene may require a search with 
markers equally spaced along the entire human genome.
II 4
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Appendix
Members o f  the International Hyper IgD study group are as f o l ­
lows: J.P.H. Drenth, J.W.M. van der Meer. C.M.R. Weemaes, Uni­
versity Hospital St Radboud, Nijmegen, The Netherlands; J.W.J. 
Bijlsma, University Hospital Utrecht. E.R. de Graeff-Meeder, Wil- 
helmina Children’s Hospital, Utrecht, The Netherlands; M. Al- 
calay, Hospital Jean Bernard, Poitiers, France; C. Chapelon-Abric, 
Hospital Pitié Salpétrière; M.F. Kahn, Hospital Bichat, A.M. 
Prieur, Hospital Necker Enfants Malades, J. Sibilia, Hospital St. 
Louis, Paris, France; C. Morand, Hospital Augustin Morvan, 
Brest, France; R.J. Powell, Queen's Medical Centre, Nottingham, 
United Kingdom: R. Topaloglu, U. Saatçi, Hacettepe Children's 
Hospital, Ankara, Turkey; R. Scolozzi, University of Ferrara, Fer­
rara, Italy; P. Lazzarin, University of Padova, Padova, Italy; C.M. 
Monciotti, University of Padova, Padova, Italy; J. Demonty. Uni­
versity of Liege, Liege, Belgium; D. Jilek, Regional Hygiene In­
stitute. listi nad Labem, Czech Republic; S. Miyagawa, Nara Med­
ical University. Kashihara City, Japan; T. Español, Ciutat Sanitàri 
i Universitaria, Vail d 'Hebron, Spain. The underlined members of 
the study group provided blood samples and clinical data from 
their patients and families.
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